Trastuzumab

Results: 445



#Item
1Biocon Limited: Q1 FY17 Earnings Call Transcript July 22, 2016 Participants from Biocon’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and Managing Director Arun Chandravarkar: CEO & Jt. Managing Director

Biocon Limited: Q1 FY17 Earnings Call Transcript July 22, 2016 Participants from Biocon’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and Managing Director Arun Chandravarkar: CEO & Jt. Managing Director

Add to Reading List

Source URL: www.biocon.com

Language: English - Date: 2016-08-03 03:39:33
2Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20

Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20

Add to Reading List

Source URL: www.biocon.com

Language: English - Date: 2016-07-21 09:25:25
3Patientinformation – tillæg til DBCG 2015-b,t og 2015-d,t (Trastuzumab) Antistofbehandling af brystkræft efter operation Denne information supplerer vores mundtlige information om den behandling, vi anbefaler dig. I

Patientinformation – tillæg til DBCG 2015-b,t og 2015-d,t (Trastuzumab) Antistofbehandling af brystkræft efter operation Denne information supplerer vores mundtlige information om den behandling, vi anbefaler dig. I

Add to Reading List

Source URL: www.dbcg.dk

Language: Danish - Date: 2016-02-29 07:46:05
    4FINAL Press Release Biocon Reports a Strong Q1FY17 Revenues at Rs 952 Crore, up by 11 %; EBITDA Up 15% to Rs 271 Crore

    FINAL Press Release Biocon Reports a Strong Q1FY17 Revenues at Rs 952 Crore, up by 11 %; EBITDA Up 15% to Rs 271 Crore

    Add to Reading List

    Source URL: www.biocon.com

    Language: English - Date: 2016-07-21 12:08:20
    5Investor Presentation June 2016 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS │ BLOOMBERG: BIOS IN │ WWW.BIOCON.COM

    Investor Presentation June 2016 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS │ BLOOMBERG: BIOS IN │ WWW.BIOCON.COM

    Add to Reading List

    Source URL: www.biocon.com

    Language: English - Date: 2016-06-15 08:00:16
    6EDITORIAL STAFF From the Editor Debu Tripathy, MD Editor-in-Chief

    EDITORIAL STAFF From the Editor Debu Tripathy, MD Editor-in-Chief

    Add to Reading List

    Source URL: gotoper-com.s3.amazonaws.com

    Language: English - Date: 2016-08-08 16:43:50
    7Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 217 Pharmacometric Models for Antibody Drug Conjugates and Taxanes in HER2+ and HER2Breast Cancer

    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 217 Pharmacometric Models for Antibody Drug Conjugates and Taxanes in HER2+ and HER2Breast Cancer

    Add to Reading List

    Source URL: uu.diva-portal.org

    Language: English - Date: 2016-05-25 07:51:34
    8Digital Unix 4.0 Upgrade Plan

    Digital Unix 4.0 Upgrade Plan

    Add to Reading List

    Source URL: www.cgl.ucsf.edu

    Language: English - Date: 2005-08-06 16:58:13
    9若手研究者インターナショナル・トレーニング・プログラム(ITP) バイオインフォマティクスとシステムズバイオロジーの国際連携教育研究プログラム 応募書類 Name:

    若手研究者インターナショナル・トレーニング・プログラム(ITP) バイオインフォマティクスとシステムズバイオロジーの国際連携教育研究プログラム 応募書類 Name:

    Add to Reading List

    Source URL: www.bic.kyoto-u.ac.jp

    Language: English - Date: 2014-08-18 20:02:48
    10Microsoft PowerPoint - Vyberg-Belgium-0611

    Microsoft PowerPoint - Vyberg-Belgium-0611

    Add to Reading List

    Source URL: www.nordiqc.org

    Language: English - Date: 2011-06-18 08:43:15